All systems go for AFT Pharmaceuticals

All systems go for AFT Pharmaceuticals
Hartley Atkinson: negative economy won't impact growth. (Image: Supplied)
Brent Melville
AFT Pharmaceuticals expects to make inroads into the Australian market on the strength of its new Maxigesic sinus and pain treatment and hot drink sachet products.Product sales in Australia have steadily improved after the listed pharmaceutical group's successful legal appeal against British-based consumer products giant Reckitt Benckiser, allowing AFT to compare its products with paracetamol and ibuprofen in its advertising.That helped push overall product sales and royalties up by 30% during the half year to September 2022, though first-h...

More Markets

F&P Healthcare FY25 guidance to be in the spotlight
Markets

F&P Healthcare FY25 guidance to be in the spotlight

Analysts are upbeat about FY25 revenue potential. 

Rua Gold gets exploration green light
Markets

Rua Gold gets exploration green light

The company hopes to begin exploration drilling in Coromandel by the year's end.

The Madness of Crowds…
Markets

Simon Robertson: The Madness of Crowds…

It's a lot of fun to go down rabbit holes and get your head around new businesses. 

Simon Robertson 25 May 2024
Dimming faith in interest rate cuts give NZ market the jitters
Markets Market close

Dimming faith in interest rate cuts give NZ market the jitters

Small slip in NZ follows sharp fall on Wall Street.

Graham Skellern 24 May 2024